Table 5.
Comparison of the prevalence of metabolic syndrome and its components in groups with normal TSH levels.
| TSH (mIU/L) | P | |||
|---|---|---|---|---|
| 1.01–2.14 (n = 289) | 2.15–3.07 (n = 287) | 3.08–5.72 (n = 290) | ||
| Overweight/obesity | ||||
| Prevalence (%) | 19.4 | 24.6 | 21.9 | 0.315 |
| OR | 0.752 | Ref. | 0.827 | |
| Hyperglycemia | ||||
| Prevalence (%) | 5.9 | 6.6 | 6.6 | 0.923 |
| OR | 0.988 | Ref. | 0.990 | |
| Hypertension | ||||
| Prevalence (%) | 15.7 | 17.4 | 19.8 | 0.439 |
| OR | 0.931 | Ref. | 1.166 | |
| Low HDL-C | ||||
| Prevalence (%) | 40.8 | 48.9 | 49.3 | 0.070 |
| OR | 0.681∗ | Ref. | 1.020 | |
| High TG | ||||
| Prevalence (%) | 7.3 | 10.5 | 11.7 | 0.179 |
| OR | 0.728 | Ref. | 1.004 | |
| MS | ||||
| Prevalence (%) | 4.9 | 9.2 | 9.0 | 0.099 |
| OR | 0.618 | Ref. | 0.722 | |
Ref. is control group; compared with mid-range TSH group, *P < 0.05; the prevalence of overweight/obesity, after adjusting for age, gender, and HOMA-IR; others, after adjusting for age, gender, HOMA-IR, and BMI.